ScholarIQanswers from OpenAlex

Gene expression profiles in stages II and III colon cancers: application of a 128-gene signature

PaperCitations, authors & open-access status

Gene expression profiles in stages II and III colon cancers: application of a 128-gene signature is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Gene expression profiles in stages II and III colon cancers: application of a 128-gene signature have?

ScholarIQcitation count

Gene expression profiles in stages II and III colon cancers: application of a 128-gene signature has 39 citations in the OpenAlex counts ScholarIQ stores.

When was Gene expression profiles in stages II and III colon cancers: application of a 128-gene signature published?

ScholarIQyear

Gene expression profiles in stages II and III colon cancers: application of a 128-gene signature has 2012 year in the ScholarIQ index.

What is the open-access status of Gene expression profiles in stages II and III colon cancers: application of a 128-gene signature?

ScholarIQoa status

Gene expression profiles in stages II and III colon cancers: application of a 128-gene signature has closed oa status in the ScholarIQ index.

What is the DOI of Gene expression profiles in stages II and III colon cancers: application of a 128-gene signature?

ScholarIQdoi

The DOI for Gene expression profiles in stages II and III colon cancers: application of a 128-gene signature is on the source record.

What is the PMID of Gene expression profiles in stages II and III colon cancers: application of a 128-gene signature?

ScholarIQpmid

The PMID for Gene expression profiles in stages II and III colon cancers: application of a 128-gene signature is on the source record.

What is the OpenAlex record for Gene expression profiles in stages II and III colon cancers: application of a 128-gene signature?

ScholarIQopenalex

The OpenAlex for Gene expression profiles in stages II and III colon cancers: application of a 128-gene signature is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial